 |
|
|
|
 |
Doctoral Programs adapted to ESSE
|
 |
|
|
|
|
|
DOCTORAL PROGRAMS
|
|
|
| Identificative data of the program |
|
|
Code
|
HDK0X
|
|
Denomination
|
Drug Research, Development and Control
|
|
Areas of the program
|
Health Sciences
|
|
Maximum number of students
|
25
|
|
URL of the program
|
|
|
ADMISSION AND ACCESS OPEN
|
|
| Coordinator |
|
Name
|
Maria Luisa García López
|
|
Centre
|
Faculty of Pharmacy and Food Science
|
|
E-mail
|
marisagarcia@ub.edu
|
|
Telephone
|
934024552
|
|
Fax
|
934035987
|
| Faculty/Registering Centre |
| |
|
Faculty of Pharmacy and Food Science
|
|
SED of Medicine and Health Sciences (Clínic)
|
| General objectives of the program |
The UB's PhD programme in Research, Development and Control of Medicines is aimed at responding to social demand in the field of pharmaceutical R&D&I, training doctors to become highly qualified professionals in this sector.
It is the ideal platform for acquiring advanced training in the different stages of drug development. The research and development of new active ingredients or new pharmaceutical forms with high added value is one of the main challenges facing the pharmaceutical industry. The aim of this PhD is to provide advanced, specialised and multidisciplinary training that will facilitate the employment of graduates in research centres or companies in the pharmaceutical and related sectors.
Prestigious scientists and highly qualified professionals from the pharmaceutical industry participate in the programme, making it an international benchmark. |
| |
| Specific requirements and criteria for admission to the doctoral program and applicant merit rating |
In general, the recommended applicant profile for direct access to the doctoral programme in Drug Research, Development and Control is that of a graduate with a master's degree in an area of the health sciences, preferably the UB's master's degree in Drug Research, Development and Control. The ideal candidate for this programme must have solid training in the field of health sciences, chemistry or related sciences, and a clear interest in research in the field of the pharmaceutical industry. Candidates must be able to understand the latest advances, innovative experimental techniques and management models in the pharmaceutical sector. As such, credit is given for master's degrees in the health sciences (pharmacy and medicine), chemistry and related sciences (chemistry, biochemistry, chemical engineering, agronomy, and food science and technology), biotechnology, biology or veterinary science, which provide sufficient training to access specialized courses in areas of the pharmaceutical industry.
If the candidate's postgraduate training does not fit the requisite profile, the Academic Committee will assess the suitability of previous studies and the full curriculum vitae, and request a report from the research group that the applicant would join.
Access and admission
The admission procedure for the doctoral programme in Drug Research, Development and Control
is overseen by the Academic Committee.
The Committee will consider the candidate's merits:
1. Curriculum vitae. The Committee will assess the candidate's research experience, giving credit for previous knowledge of the programme's research areas, publications and conference papers related to the pharmaceutical industry, and a good command of scientific English. If candidates do not have official language certificates, their English language skills will be assessed in an interview. Weighting: 35%.
2. Academic record for the qualification used for admission (bachelor's degree / master's degree) and other academic merits. In particular, the Committee will assess whether the candidate has sufficient training to begin a thesis on research topics related to the programme content, looking primarily at the grade point averages obtained for bachelor's degrees and master's degrees. For candidates whose university master's degree was not completed at the UB, the Committee will also take into account quality indicators for the master's degree and the university at which it was taken. Weighting: 40%.
3. Statement of interest. The statement of interest must clearly indicate the candidate's reasons for applying to a doctoral programme in Drug Research, Development and Control, and include a brief description of the proposed research project. Credit will also be given for a particular interest in the research activities carried out by staff assigned to the doctoral programme. To clarify the reasons given in the statement of interest, some candidates may also be asked to attend a personal interview. Weighting: 20%.
4. Letters of recommendation. Letters of recommendation must refer to the candidate's previous training, analytical skills and general motivation for learning. Weighting: 5% |
| |
| Salidas profesionales |
The title of Doctor in Research, Development and Control of Medicines is an indication that this professional has acquired a suitable training to develop independent and quality research in the field of R&D&I of medicines. Regardless of the research orientation of the thesis work, the PhD degree is essential for the pursuit of a scientific and academic career focused on employment in Research Centres and Universities.
This doctorate is a recognition for those professionals who want to develop their work in the business world, both in R&D departments and in other areas of the pharmaceutical, biotechnological or related industries. |
| |
| Idiomes del programa |
| Catalan, Spanish, English |
| |
| Offered research lines |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
|
|
|
Planificació Academicodocent
© Universitat de Barcelona
05/05/2024 12:08
|
Àrea de Tecnologies de la Informació i la Comunicació
Aplicacions - Projectes de Gestió Acadèmica (GIGA)
Darrera Modificació Programa: 20/12/2022 07:53
Darrera Modificació Model: 02/07/2018 10:36
|
|